Nootropic Agents - Therapeutic use
Research News and Information

Sunday, November 22, 2009

Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.

30 Aug 2009 Cognitive deficits are commonly associated with maintenance electroconvulsive therapy (ECT). Treatment of these cognitive deficits is important but difficult. Cholinergic pathways are involved in these side effects, and donepezil, a cholinesterase ... Read more...

Treatment of mild cognitive impairment (MCI).

30 Jul 2009 Mild cognitive impairment (MCI), an intermediate stage between normalcy and dementia, is characterized by fewer symptoms and less functional decline than dementia with less established biological disease processes and is an attractive target for ... Read more...

The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome.

30 Jul 2009 The objective of our study was to assess the efficacy and safety of donepezil in young adults with Down syndrome (DS) but no evidence of Alzheimer disease (AD). A 12-week, randomized, double-blind, placebo-controlled study with a 12-week, open-label ... Read more...

Latest indexed articles for 'Nootropic Agents - Therapeutic use'

These are the very latest articles for this heading:

• Donepezil treatment of patients with MCI: a 48-week randomized, placebo- controlled trial. Nov 2009
• [Final report is now available. IQWiG doubts the effectiveness of memantine] 22 Sep 2009
• Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report. 30 Aug 2009
• Medication for dementia. 30 Aug 2009
• Treatment of mild cognitive impairment (MCI). 30 Jul 2009
• The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. 30 Jul 2009
• DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT. 22 Jul 2009
• Recovery of cognitive dysfunction in a case of delayed encephalopathy of carbon monoxide poisoning after treatment with donepezil hydrochloride. 29 Jun 2009
• Response to "Results, rhetoric, and randomized trials: the case of donepezil". 29 Jun 2009
• Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET. 22 Jun 2009
• Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. 17 Jun 2009
• [Management and therapy of Alzheimer's disease. Recommendations of a general practitioners' guideline] 9 Jun 2009
• [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease] 3 Jun 2009
• Publication bias perpetuates use of ineffective drugs in stroke. 30 May 2009
• Pharmacotherapy in stroke rehabilitation. 30 May 2009
• Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. 30 May 2009
• [Antidementia drugs] 30 May 2009
• Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial. 12 May 2009
• Sequelae of closed craniocerebral trauma and the efficacy of piracetam in its treatment in adolescents. 29 Apr 2009
• Therapeutic targets for Alzheimer's disease. 29 Apr 2009

See a longer list of these articles.

Technical information about 'Nootropic Agents'

Definition: Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. While no potent nootropic drugs have yet been accepted for general use, several are being actively investigated.

Registry Number: 0

Descriptor UI: D018697

Alternative terms: Nootropic Agents; Agents, Nootropic; Nootropics; Cognitive Enhancers; Enhancers, Cognitive; Nootropic Drugs; Drugs, Nootropic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.427.637;

Online Note: use PSYCHOTROPIC DRUGS to search NOOTROPIC DRUGS 1990-94

History Note: 95; NOOTRPIC DRUGS was see PSYCHOTROPIC DRUGS 1990-94

Technical Notes: CNS agents; from Greek nous, mind; GEN or unspecified: prefer specifics